An inducible mouse model for epidermolysis bullosa simplex: Implications for gene therapy

Journal of Cell Biology

Volumn 153, Issue 3, 2001, Pages 651-656

  Cao, Tongyu ^a   Longley, Mary Ann ^a   Wang, Xiao Jing ^a   Roop, Dennis R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Epidermal stem cells; Epidermolysis bullosa simplex; Gene targeting; Gene therapy; Keratins

Indexed keywords

KERATIN; CRE RECOMBINASE; CYTOKERATIN 14; INTEGRASE; KRT1 14 PROTEIN, MOUSE; KRT1-14 PROTEIN, MOUSE; KRT14 PROTEIN, HUMAN; LUTEOLYTIC AGENT; MIFEPRISTONE; VIRUS PROTEIN;

ALLELISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPIDERMIS CELL; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE ACTIVATION; GENE MUTATION; GENE TARGETING; GENE THERAPY; MOSAICISM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; ANIMAL; DISEASE MODEL; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; SOUTHERN BLOTTING; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALIA; MEARA;

ANIMALS; BLOTTING, SOUTHERN; DISEASE MODELS, ANIMAL; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; INTEGRASES; KERATIN-14; KERATINS; LUTEOLYTIC AGENTS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MIFEPRISTONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; VIRAL PROTEINS;

EID: 0035809198     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.152.3.651     Document Type: Article

References (28)

1. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide
2. Epidermolysis bullosa herpetiformis Dowling-Meara. Report of a case and pathomorphogenesis
3. Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders
4. Characterization of an inducible, epidermal-specific knockout system: Differential expression of lacZ in different Cre reporter mouse strains
5. A human keratin 14 "knockout": The absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein
6. Keratin 14 gene mutations in patients with epidermolysis bullosa simplex
7. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide
8. The cellular and molecular biology of keratins: Beginning a new era
9. Epidermolysis bullosa dermatitis herpetiformis
10. The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: Use of site-specific mutagenesis and recombinant protein expression
11. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex
12. Regulation of Cre recombinase activity by the synthetic steroid RU 486
13. Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex
14. The basal keratin network of stratified squamous epithelia: Defining K15 function in the absence of K14
15. Hereditary epidermolysis bullosa
16. Epidermolysis bullosa simplex (Dowling-Meara). A clinicopathological review
17. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
18. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients
19. Genetic and clinical mosaicism in a type of epidermal nevus
20. Measurement of the transit time for cells through the epidermis and stratum corneum of the mouse and guinea-pig
21. Patterns of expression and organization of cytokeratin intermediate filaments
22. Analysis, diagnosis, and molecular genetics of keratin disorders
23. A functional "knockout" of human keratin 14
24. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer
25. Molecular and cellular biology of intermediate filaments
26. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease
27. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas
28. Delayed wound healing in keratin 6a knockout mice